BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
90 hedge funds and large institutions have $121M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
53% less call options, than puts
Call options by funds: $596K | Put options by funds: $1.26M
Holders
90
Holding in Top 10
–
Calls
$596K
Puts
$1.26M
Top Buyers
| 1 | +$3.44M | |
| 2 | +$2.63M | |
| 3 | +$2.3M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$947K |
| 5 |
Millennium Management
New York
|
+$798K |
Top Sellers
| 1 | -$5.78M | |
| 2 | -$4.16M | |
| 3 | -$1.31M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.28M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$908K |